These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 825024)

  • 61. Molecular structures and functions of pyocins S1 and S2 in Pseudomonas aeruginosa.
    Sano Y; Matsui H; Kobayashi M; Kageyama M
    J Bacteriol; 1993 May; 175(10):2907-16. PubMed ID: 8491711
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Induced changes in the surface of Neisseria gonorrhoeae.
    Norrod EP; Burnham JS; Williams RP; Ding MJ
    Can J Microbiol; 1983 May; 29(5):584-92. PubMed ID: 6411313
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reevaluation of bacteriocinogeny in Neisseria gonorrhoeae.
    Knapp JS; Falkow S; Holmes KK
    J Clin Pathol; 1975 Apr; 28(4):274-8. PubMed ID: 805162
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Pyocin typing of Pseudomonas aeruginosa strains isolated from various sources].
    Kantarci G
    Mikrobiyol Bul; 1992 Jan; 26(1):17-25. PubMed ID: 1574018
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relationship of resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa.
    Petrocheilou-Malliara K; Koukoubanis N; Legakis N
    Chemioterapia; 1987 Jun; 6(2 Suppl):199. PubMed ID: 3151341
    [No Abstract]   [Full Text] [Related]  

  • 66. Competition in Biofilms between Cystic Fibrosis Isolates of
    Oluyombo O; Penfold CN; Diggle SP
    mBio; 2019 Jan; 10(1):. PubMed ID: 30696740
    [No Abstract]   [Full Text] [Related]  

  • 67. Purification and characterization of pyocins from Pseudomonas aeruginosa.
    Al-Shibib A; Al-Mudhaffar S; Al-Ani F; Hassan F
    Folia Microbiol (Praha); 1985; 30(1):25-9. PubMed ID: 3920127
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of FiuA Outer Membrane Receptor Polymorphism on the Resistance of
    Latino L; Patin D; Chérier D; Touzé T; Pourcel C; Barreteau H; Mengin-Lecreulx D
    J Bacteriol; 2019 Jul; 201(13):. PubMed ID: 30988031
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model.
    Scholl D; Martin DW
    Antimicrob Agents Chemother; 2008 May; 52(5):1647-52. PubMed ID: 18332164
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epidemiology of Pseudomonas aeruginosa infections: determination by pyocin typing.
    Bruun FN; McGarrity GJ; Blakemore WS; Coriell LL
    J Clin Microbiol; 1976 Mar; 3(3):264-71. PubMed ID: 818110
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Pyocin typing of 111 strains of Pseudomonas aeruginosa isolated in Tuscany, using the Gillies and Govan method].
    Degl'Innocenti R; Berdondini I; Urbano P
    Ann Sclavo; 1978; 20(4):616-24. PubMed ID: 111627
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High prevalence of lipopolysaccharide mutants and R2-pyocin susceptible variants in
    Mei M; Pheng P; Kurzeja-Edwards D; Diggle SP
    Microbiol Spectr; 2023 Dec; 11(6):e0177323. PubMed ID: 37877708
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The R-type pyocin of Pseudomonas aeruginosa C is a bacteriophage tail-like particle that contains single-stranded DNA.
    Lee FK; Dudas KC; Hanson JA; Nelson MB; LoVerde PT; Apicella MA
    Infect Immun; 1999 Feb; 67(2):717-25. PubMed ID: 9916082
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synergistic activity of gentamicin plus carbenicillin upon Pseudomonas aeruginosa: its relationship with pyocin and antibiotic susceptibility.
    Zemelman R; Mondaca MA; Monge A
    Microbios; 1977; 18(72):79-86. PubMed ID: 417232
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy of species-specific protein antibiotics in a murine model of acute Pseudomonas aeruginosa lung infection.
    McCaughey LC; Ritchie ND; Douce GR; Evans TJ; Walker D
    Sci Rep; 2016 Jul; 6():30201. PubMed ID: 27444885
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bacteriocin-mediated competition in cystic fibrosis lung infections.
    Ghoul M; West SA; Johansen HK; Molin S; Harrison OB; Maiden MC; Jelsbak L; Bruce JB; Griffin AS
    Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26311664
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Defective pyocin particles produced by some mutant strains of Pseudomonas aeruginosa.
    Shinomiya T; Osumi M; Kageyama M
    J Bacteriol; 1975 Dec; 124(3):1508-21. PubMed ID: 811648
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Relations between antibiotic resistance and pyocin P3 resistance in Pseudomonas aeruginosa mutants].
    García-Quintana HG; Wilckens R
    Zentralbl Veterinarmed B; 1983 Apr; 30(3):169-74. PubMed ID: 6408850
    [No Abstract]   [Full Text] [Related]  

  • 79. [Antibiotic sensitivity and pyocin dependence of clinical strains of Ps. aeruginosa].
    Savitskaia KI; Levina EN
    Antibiotiki; 1977 Dec; 22(12):1117-21. PubMed ID: 413475
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mode of action of pyocin R1.
    Iijima M
    J Biochem; 1978 Feb; 83(2):395-402. PubMed ID: 416014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.